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Abstract
Background: It is estimated that 60 million computed tomography (CT) scans were performed
during 2006, with approximately 11% of those performed on children age 0–15 years. Various types
of gonadal shielding have been evaluated for reducing exposure to the gonads. The purpose of this
study was to quantify the radiation dose reduction to the gonads and its effect on image quality
when a wrap-around male pediatric gonad shield was used during CT scanning. This information is
obtained to assist the attending radiologist in the decision to utilize such male gonadal shields in
pediatric imaging practice.
Methods: The dose reduction to the gonads was measured for both direct radiation and for
indirect scattered radiation from the abdomen. A 6 cm3 ion chamber (Model 10X5-6, Radcal
Corporation, Monrovia, CA) was placed on a Humanoid real bone pelvic phantom at a position of
the male gonads. When exposure measurements with shielding were made, a 1 mm lead wrap-
around gonadal shield was placed around the ion chamber sensitive volume.
Results: The use of the shields reduced scatter dose to the gonads by a factor of about 2 with no
appreciable loss of image quality. The shields reduced the direct beam dose by a factor of about 35
at the expense of extremely poor CT image quality due to severe streak artifacts.
Conclusion: Images in the direct exposure case are not useful due to these severe artifacts and
the difficulties in positioning these shields on patients in the scatter exposure case may not be
warranted by the small absolute reduction in scatter dose unless it is expected that the patient will
be subjected to numerous future CT scans.
Background
The use of computed tomography (CT) scanning has
increased rapidly since its introduction in the early 1970s.
During the 1990s CT usage almost doubled, representing
about 11% of radiology procedures in 1999 [1]. These val-
ues are consistent with a United States estimated rate for
CT of 91 per 1000 population through the year 2000 [2].
In 1999, about 11% of all CT scans were performed on
children age 0–15 years [1]. It is expected that the use of
the modality will increase as the number of detectors and
the clinical utility of CT is increased. It has been estimated
that the number of CT scans performed annually has
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steadily increased in the U.S. from 2.8 million in 1981 [3]
to 20 million in 1995 [2] and 60 million in 2006 [4], a
number that seems destined to grow substantially. When
using different sized acrylic phantoms to represent a range
of pediatric and adult sizes undergoing CT with a typical
120 kVp x-ray beam, doses to the adult body range from
15–35 mGy while doses to the pediatric body are higher
at 29–68 mGy using adult technique factors (milliam-
pere-seconds)[5]. Similarly measured CT doses to the
adult head range from 60–115 mGy while doses to the
pediatric head are about 30% higher at 78–152 mGy
using adult technique factors [5]. Also, when you have
similar techniques, the effective doses are substantially
higher in children by a factor of about 2 to 4 [6].
Simple dose reduction methods that do not impair diag-
nostic image quality should be considered for clinical use
[7] in an effort to reduce risks of induced cancers and
other effects [8]. Various authors have suggested that pedi-
atric CT doses could be reduced by 30–50% or, more rel-
ative to adult doses, primarily by reducing the
milliampere-seconds utilized, with no loss of diagnostic
accuracy [5,9-14]. In a further attempt at reducing expo-
sures to specific areas of the pediatric body, physicians are
increasingly considering the use of shielding devices,
including specially designed gonadal shielding for male
testes. CT represents a shielding challenge because of the
confounding dose from both the primary x-ray beam and
the significant scatter component in the body during the
multi-slice scanning.
The current approved recommendations by the Interna-
tional Commission on Radiological Protection suggests
that the weighting factor for the male gonads is 0.20 based
on the radiation sensitivity of the gonads due to the risk
of mutagenesis [15], with the dose to the gonads therefore
contributing 20% of the effective whole-body dose (note
that the most recent draft recommendations suggest a
reduced weighting factor of 0.08 for the gonads [16]). Var-
ious shielding designs have been developed over the years
to reduce gonadal doses including lead blankets, bismuth
shielding, clam-shell style male testicular shields, and
flexible shields.
The goal of our phantom study was obtain information to
assist the attending radiologist in the decision to utilize
such male gonadal shields in pediatric imaging practice.
Although previous studies have evaluated various male
gonad shielding designs, we set out to measure the effect
of a specific design made up of a 1 mm lead equivalent,
flexible, velcro-held, wrap-around pediatric male gonad
shield (Flexible gonad protector, Dr. Goos-Suprema, Hei-
delberg, Germany) on the testicular radiation exposure
from both the primary beam and the scatter component
during abdominal and pelvic helical CT scans using tech-
niques utilized at our institution. In addition, the effect of
the presence of the shield on the CT image was also eval-
uated.
Methods
The study was performed using a sectional pelvic phan-
tom (pelvic real-bone sectional phantom, Humanoid Sys-
tems – currently Radiology Support Devices, Inc., Long
Beach CA, USA) (Figure 1), and as such, institutional
review board approval was not required since no testing
was performed on human subjects. The phantom consists
of an adult male human skeleton embedded in tissue sim-
ulating plastic [17,18]. It is designed to simulate an aver-
age large (e.g. teen) pediatric or small adult patient's
interaction with x-rays over the diagnostic energy range.
No simulated organs exist within the phantom itself. A 6
cm3 ion chamber (Model 10X5-6, Radcal Corporation,
Monrovia, CA, USA) was placed on the phantom at the
position of the male gonads (approximately 5 cm below
the symphysis pubis and centered between the upper
thighs) to measure the exposure in Roentgens (R) at this
location (Figure 2). For the measurement and techniques
employed, it was assumed that 1 Gytissue ≈ 1R × 0.91 (Gytis-
sue/R) [19].
When shielded exposure measurements were made, a 1
mm lead wrap-around gonadal shield (Figure 3) was
placed around the ion chamber sensitive volume. As such,
the ion chamber itself represented the gonads. The
absence of testicular tissue equivalent material will have a
minimal effect on results because it is expected that the
significant majority of the scatter component is propa-
gated from the body and pelvic bone tissues. The study
geometry mimics the expected use of the shield during
clinical applications
Two trials were evaluated. In the first trial, abdomen scans
were performed to examine the effect of the shielding on
scattered radiation only. For this abdominal scan trial, the
ion chamber representing the testes, and the gonad shield
were specifically placed approximately 5–10 cm outside
of the scanning range so that the measured exposure rep-
resented only the scatter component. The abdomen of the
phantom was scanned for this first trial using a routine
abdominal examination protocol (Table 1, CT technique
factors) on a 16 slice CT scanner (Lightspeed 16, General
Electric, Waukesha, WI, USA) in a craniocaudal direction
starting at a location just above the diaphragm and ending
just above the bottom edge of the symphysis. The result-
ing scatter exposure was measured both with and without
the gonadal shield in place. Because of limited access to
the CT scanner, measurements using the large shield (650
cm3) were able to be repeated five times and only one
measurement each were made using the small (150 cm3)
and medium (450 cm3) shields.BMC Medical Imaging 2007, 7:5 http://www.biomedcentral.com/1471-2342/7/5
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In the second trial, a pelvis scan was performed to exam-
ine the effect of shielding on direct radiation (both pri-
mary and exit). In this trial, the pelvis of the phantom was
scanned using the same routine abdominopelvic exami-
nation protocol (Table 1) in a craniocaudal direction
from the area just above the bottom edge of the symphysis
to the upper thigh. The resulting exposure was measured
both with and without the gonadal shield in place. For
this trial, measurements were also repeated five times for
the large shield and one time each for the small and
medium shields.
For both trials, the radiation exposures to the testicular
region with and without the wrap-around gonadal shield-
ing were compared using the Student's t test. Statistical
significance was set at a p value of less than 0.05.
During both trials, representative CT images were
obtained in order to evaluate image quality on the basis of
noise measurements and visual inspection of image arti-
facts with and without the gonadal shield in place.
Results
Tables 2 and 3 summarize the results of the phantom
measurements, listing the gonad exposures without
shields and with the large, medium, or small gonad shield
in place. For the first technique, employing an abdominal
scan with scatter dose to the gonads, the average measured
gonad exposure was 68.6 mR (~ 0.62 mGy) without the
gonad shield and was reduced to 29.1, 33.2, and 39.8 mR
when the large, medium, or small shields were used,
respectively. The shields appear to reduce scatter exposure
to the gonads from an abdominal CT scan by about a fac-
tor of 2 (Table 2), a value shown to be statistically signifi-
cant (t = 86, p < 0.001) with an absolute reduction in
exposure of about only 20–30 mR. For the second tech-
nique, employing a pelvic scan with direct exposure to the
gonads, the average measured gonad exposure was 4806
mR (~ 43.7 mGy) without the gonad shield and was
reduced to 137.2, 171.4, and 265.4 mR when the large,
medium, or small shields were used, respectively. The
shields appear to reduce the direct exposure to the gonads
by about a factor of 35 (Table 3), a value shown to be sta-
tistically significant (t = 1141, p < 0.001).
CT image of Humanoid phantom showing the location of the  ion chamber at the level of the pelvis Figure 2
CT image of Humanoid phantom showing the loca-
tion of the ion chamber at the level of the pelvis. Ion 
chamber was located to approximate male gonad geometry 
(window level set at maximum to enhance the view of the 
chamber).
Humanoid abdominal/pelvic phantom Figure 1
Humanoid abdominal/pelvic phantom.BMC Medical Imaging 2007, 7:5 http://www.biomedcentral.com/1471-2342/7/5
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Images of an abdominal region were evaluated both with
(Figure 4(A)) and without (Figure 4(B)) the gonad shield
in place to measure noise within the same region. Noise
was identical for each image, with a standard deviation of
5.5 Hounsfield Units in the region of interest (i.e. with or
without the shield). When images of the pelvic region
were evaluated with the gonad shield in place, severe
streaking and image degradation was noted, as shown in
Figure 5.
Discussion
For the abdominal scans without gonadal shielding, the
scatter exposure component to the gonads represented
about 1.5% of the exposure to the gonads during a direct
pelvic scan without gonadal shielding. For the abdominal
scan, the large wrap-around shields appear to reduce the
scatter exposure to the gonads by about 58%. For the
direct pelvis scan, the exposure to the gonads was much
higher, at 4820+/-14 mR, and the large wrap-around
shields provided a more substantial shielding effect,
reducing the direct beam exposure to the gonads by about
97%.
Price, et al [20] have performed a similar study that uti-
lized a male Alderson therapy phantom, a 1 mm lead rub-
ber wrap-around gonad shield, and lithium borate
thermoluminescent dosimeters to measure doses to a tes-
tes phantom modeled from a single-slice CT scan. They
found that doses to the gonads could be reduced by about
77% for scans outside of the gonadal area. They also
reported severely degraded images for direct pelvic scans.
Hidajat et al. [21] used a male Alderson radiation therapy
phantom and protected the testes with a 1 mm lead testic-
ular capsule to obtain a 95% reduction in dose. Hohl et al.
[7] measured the dose to the gonads for 66 men (34 with
1 mm lead capsule shields and 32 without shields) that
underwent routine abdominopelvic multi-detector CT
with a 16 slice machine by using lithium fluoride thermo-
luminescent dosimeters. They report an 87% reduction in
dose to gonads during abdominal scans. Table 4 com-
pares the results of these literature reports including type
of study, scanning protocol, testicular dose and percent
reduction. While the doses to the shielded gonads are con-
sistent with the literature values, there are differences in
overall percent reduction that are most likely related to
Table 2: Measured ion chamber readings (mR) representing gonadal exposure from an abdominal CT scan
Scan # No Shield Large Shield (650 cm3) Medium Shield (450 cm3) Small Shield (150 cm3)
1 69.7 29.4 33.2 49.8
26 8 . 7 2 9 . 5
36 8 . 9 2 8 . 3
46 8 . 3 2 9 . 0
56 7 . 2 2 9 . 2
Average +/- std.dev. 68.6 +/- 0.9 29.1 +/- 0.5
% Reduction 58% 52% 42%
Reduction Factor 2.4 2.1 1.7
1 mm lead wrap-around gonad shields in three sizes Figure 3
1 mm lead wrap-around gonad shields in three sizes. 
Flexible gonad protector, Dr. Goos-Suprema, Heidelberg, 
Germany.
Table 1: CT technique factors utilized in this study
Parameter Value
Technique Adult – Helical
kVp 120
mA 260
Time per rotation (s) 0.7
mAseff 194
Scan Field of View Large
Z-axis collimation (mm) 1.25
Table speed (mm/rot) 18.75
Pitch 0.938
Reconstructed Scan Width (mm) 5BMC Medical Imaging 2007, 7:5 http://www.biomedcentral.com/1471-2342/7/5
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shielding types, setup, CT parameters, x-ray beam spec-
trum, geometry, and/or measurement techniques.
Image quality does not appear to be significantly affected
when the scanned area is well outside of the gonadal
shield location as was the case of the abdominal scan (Fig-
ure 4). Image quality is significantly reduced when the
shield is located within the scan volume itself as was the
case of the pelvic scan (Figure 5). The severe streak arti-
facts, caused by the presence of lead in the shield, render
the image diagnostically unusable for most CT studies
[22]. Therefore, an understanding of patient positioning
and shielding usage is necessary. Although performed for
general radiology applications and not for CT directly, a
number of studies have shown that useful dose reduction
tools such as simple shields are not always used correctly,
resulting in inadequate coverage of reproductive organs
because the shield was not positioned correctly, or inap-
propriately shaped or sized devices were utilized [23-25].
It is important to note that while gonadal shields may
help reduce the scattered exposure component, there are
Comparison of abdominal CT images Figure 4
Comparison of abdominal CT images. Abdominal CT images of Humanoid phantom both (A) with and (B) without the 
gonad shield in place. An identical region of interest (ROI), as indicated by the circle, was selected on each image to measure 
noise.
AB
ROI ROI
Table 3: Measured ion chamber readings (mR) representing gonadal exposure from a pelvic CT scan
Scan # No Shield Large Shield (650 cm3) Medium Shield (450 cm3) Small Shield (150 cm3)
1 4820 138.2 171.4 265.4
24 8 0 0 1 3 8 . 3
34 8 0 0 1 3 8 . 9
44 8 1 0 1 3 6 . 4
54 8 0 0 1 3 4 . 2
Average +/- std.dev. 4806 +/- 8.9 137.2 +/- 1.9
% Reduction 97% 96% 94%
Reduction Factor 35 28 18BMC Medical Imaging 2007, 7:5 http://www.biomedcentral.com/1471-2342/7/5
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other simple techniques that can be explored to reduce
overall radiation exposure to pediatric patients. Geleijns
et al. suggest that adjusting techniques, such as reducing
tube current, can achieve an equal dose reduction while
yielding better image quality compared with the use of
shielding [26]. In a jointly issued guideline, the National
Cancer Institute and the Society for Pediatric Radiology
suggest the following reduction techniques for pediatric
patients [27]: (1) perform only necessary CT examina-
tions; (2) adjust exposure parameters for pediatric CT
based on child size, region scanned, organ systems
scanned, and scan resolution; and (3) to minimize the CT
examinations that use multiple scans obtained during dif-
ferent phases of contrast enhancement (multiphase exam-
inations) especially for body (chest and abdomen)
imaging. The US Food and Drug Administration has also
released recommendations for reducing pediatric CT
doses that include[28]: (1) optimizing CT settings; (2)
reducing the number of multiple scans with contrast
material; and (3) eliminating inappropriate referrals for
CT.
Conclusion
A Humanoid phantom and a 6 cm3 ion chamber can be
very useful when performing shielding evaluation studies
for CT scanning. The 1 mm wrap-around lead design for
the gonadal shields reduced the already low scatter expo-
sure to the testes by a factor of about only 2 with no appre-
ciable loss of image quality. The shields reduced the direct
beam exposure by a factor of about 35 at the expense of
extremely poor image quality due to severe streak artifacts.
Images in the direct exposure case are not useful due to
these severe artifacts and the difficulties in positioning
these shields on patients in the scatter exposure case may
not be warranted by the small absolute reduction in scat-
ter dose unless it is expected that the patient will be sub-
jected to numerous future CT scans.
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Table 4: Comparison of literature reports and present study for scattered dose reduction with the use of gonadal shields during 
abdominal CT scans (with the testes not in the direct beam)
Study Study Type Scanning Protocol Testicular Dose (mGy) % Reduction
Without Shield With Shield
Hidajat et al. 1996 [19] Phantom, 1 mm capsule Single-slice sequential, 10 mm slice, 250 
mAs/slice, 120 kV
1.46 0.07 95
Price et al. 1995 [18] Phantom, 1 mm wrap-around 
lead rubber
Single-slice spiral, 10 mm slice, 220 mA, 
120 kV
0.821 0.191 77
Hohl et al. 2005 [7] Patient, 1 mm capsule 16-slice spiral, 16 × 1.5 mm 
collimation,150 mAseff,120 kV
2.40 0.32 87
Present study Phantom, 1 mm wrap-around 
canvas
16-slice spiral, 16 × 1.25 mm collimation 
194 mAseff, 120 kV
0.62 0.26 58
1Values initially reported in mSv and were converted to mGy for comparison, assuming 1 mSv = 1 mGy.
Pelvic CT image of Humanoid phantom Figure 5
Pelvic CT image of Humanoid phantom. Pelvic CT 
image with gonad shield in place and directly situated in the 
beam. Note the severe streaking artifacts and general image 
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